Literature DB >> 15518344

Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure.

S Sabbatani1, R Manfredi, M Pavoni, A Consales, F Chiodo.   

Abstract

Although being a rare occurrence, brain cryptococcoma may represent an emerging issue, because of its relationship with a broadening range of risk factors, including malignancies, neutropenia, end-organ failure, bone marrow and solid-organ transplantation, and multiple underlying causes of primary-secondary immunodeficiency. A cerebral cryptococcoma in a chronic nephropathic HIV-negative subject with homocystinuria, completely cured with neurosurgery and voriconazole after fluconazole failure, is described.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15518344     DOI: 10.1023/b:myco.0000041904.71381.e3

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  28 in total

1.  Paradoxical intracranial cryptococcoma in a human immunodeficiency virus-infected man being treated with combination antiretroviral therapy.

Authors:  Guillaume Breton; Danielle Seilhean; Patrick Chérin; Serge Herson; Olivier Benveniste
Journal:  Am J Med       Date:  2002-08-01       Impact factor: 4.965

2.  Cryptococcosis in the AIDS era.

Authors:  D W Mackenzie
Journal:  Epidemiol Infect       Date:  1989-06       Impact factor: 2.451

3.  Bruton's agammaglobulinaemia in a child presenting with cryptococcal empyema thoracis and periauricular pyogenic abscess.

Authors:  J A Wahab; M J Hanifah; K E Choo
Journal:  Singapore Med J       Date:  1995-12       Impact factor: 1.858

4.  Multiple cryptococcal brain abscesses in systemic lupus erythematosus.

Authors:  J L Huang; M L Chou; I J Hung; K H Hsieh
Journal:  Br J Rheumatol       Date:  1996-12

Review 5.  Neuroimaging--autopsy correlations in AIDS.

Authors:  J G Smirniotopoulos; K K Koeller; A M Nelson; F M Murphy
Journal:  Neuroimaging Clin N Am       Date:  1997-08       Impact factor: 2.264

6.  [Disseminated encephalic cryptococcosis as a form of presentation of idiopathic T-CD4 lymphocytopenia].

Authors:  M J Núñez; J M de Lis; J R Rodríguez; M J Allegue; A Viladrich; C Conde; M P Santiago; M C Amigo
Journal:  Rev Neurol       Date:  1999 Feb 16-28       Impact factor: 0.870

7.  The changing face of AIDS-related opportunism: cryptococcosis in the highly active antiretroviral therapy (HAART) era. Case reports and literature review.

Authors:  R Manfredi; F Pieri; S A Pileri; F Chiodo
Journal:  Mycopathologia       Date:  1999-11       Impact factor: 2.574

Review 8.  [Neurological form of cryptococcosis. Apropos of 2 atypical cases in non HIV-infected patients].

Authors:  A Donnet; N Graziani; J R Harlé; J M Durand; A Touta; F Grisoli
Journal:  Rev Neurol (Paris)       Date:  1993       Impact factor: 2.607

Review 9.  Voriconazole: a new triazole antifungal agent.

Authors:  Margaret M Pearson; P David Rogers; John D Cleary; Stanley W Chapman
Journal:  Ann Pharmacother       Date:  2003-03       Impact factor: 3.154

10.  AIDS-associated Cryptococcus infection before and after the highly active antiretroviral therapy era: emerging management problems.

Authors:  Roberto Manfredi; Leonardo Calza; Francesco Chiodo
Journal:  Int J Antimicrob Agents       Date:  2003-10       Impact factor: 5.283

View more
  13 in total

1.  The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis.

Authors:  S Schwartz; A Reisman; P F Troke
Journal:  Infection       Date:  2011-04-22       Impact factor: 3.553

2.  Retrospective analysis of 76 immunocompetent patients with primary pulmonary cryptococcosis.

Authors:  Feng Ye; Jia-xing Xie; Qing-si Zeng; Guo-qin Chen; Shu-qing Zhong; Nan-shan Zhong
Journal:  Lung       Date:  2012-01-14       Impact factor: 2.584

3.  Influence of Experimental Cryptococcal Meningitis in Wistar Rats on Voriconazole Brain Penetration Assessed by Microdialysis.

Authors:  Izabel Almeida Alves; Keli Jaqueline Staudt; Carolina de Miranda Silva; Graziela de Araujo Lock; Teresa Dalla Costa; Bibiana Verlindo de Araujo
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

Review 4.  Fungal infections of the CNS: treatment strategies for the immunocompromised patient.

Authors:  Katharine E Black; Lindsey R Baden
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 5.  New insights in the prevention, diagnosis, and treatment of cryptococcal meningitis.

Authors:  Arthur Jackson; Charles van der Horst
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

6.  The antimicrobial activity of lapachol and its thiosemicarbazone and semicarbazone derivatives.

Authors:  Marina Azevêdo Souza; Susana Johann; Luciana Alves Rodrigues dos Santos Lima; Fernanda Fraga Campos; Isolda Castro Mendes; Heloisa Beraldo; Elaine Maria de Souza-Fagundes; Patrícia Silva Cisalpino; Carlos Augusto Rosa; Tânia Maria de Almeida Alves; Nívea Pereira de Sá; Carlos Leomar Zani
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-05       Impact factor: 2.743

7.  Diagnosis and Management of Cryptococcal Relapse.

Authors:  Abdu K Musubire; David R Boulware; David B Meya; Joshua Rhein
Journal:  J AIDS Clin Res       Date:  2013-04-29

8.  Efficacy of voriconazole in experimental Cryptococcus neoformans infection.

Authors:  Nikolaos Mavrogiorgos; Oscar Zaragoza; Arturo Casadevall; Joshua D Nosanchuk
Journal:  Mycopathologia       Date:  2006-08       Impact factor: 3.785

Review 9.  Pleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia: an unusual manifestation and a literature review.

Authors:  Mayun Chen; Xiaomi Wang; Xianjuan Yu; Caijun Dai; Dunshun Chen; Chang Yu; Xiaomei Xu; Dan Yao; Li Yang; Yuping Li; Liangxing Wang; Xiaoying Huang
Journal:  BMC Infect Dis       Date:  2015-09-22       Impact factor: 3.090

10.  Central nervous system cryptococcoma in a Ugandan patient with Human Immunodeficiency Virus.

Authors:  Sruti S Velamakanni; Nathan C Bahr; Abdu K Musubire; David R Boulware; Joshua Rhein; Henry W Nabeta
Journal:  Med Mycol Case Rep       Date:  2014-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.